Study of stem cell particles for cough after infection
Part of Lungs & breathing clinical trials.
This trial tests if inhaled particles from stem cells (called exosomes) can help with a cough that lasts 3-8 weeks after a cold or flu. It may be an option if your chest X-ray is normal and other causes of cough have been ruled out.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have a cough that started after a respiratory infection and has lasted 3 to 8 weeks.
- Your cough is dry or with a little clear phlegm, and your chest X-ray is normal.
- You rate your cough as at least 60 out of 100 on a scale where 100 is the worst possible cough.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You have not smoked in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether inhaled exosomes (tiny particles derived from stem cells) can help repair lung damage caused by immune checkpoint inhibitor therapy—a common cancer treatment. You would qualify if you developed serious lung inflammation from this therapy that hasn't fully healed with standard steroid treatment.
This study looks at how the cells lining your airways make energy and whether this is different in people with chronic cough that doesn't get better with treatment or has no clear cause. It may help doctors understand why some people cough and find new ways to treat it.
This trial is testing if inhaled steroid medications (ICS or ICS/LABA) can help people whose cough continues long after a COVID-19 infection. It is designed for adults whose cough started after a positive COVID test and has lasted more than 8 weeks without other lung issues.
This trial tests a cold-treatment procedure (cryotherapy) to treat a stubborn cough caused by nerve signaling (not infections or common allergy/acid problems). It may help people whose cough has lasted at least 8 weeks and who have already tried to rule out other causes.
This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.
This study tests a behavioral therapy delivered through group video calls to help people with a chronic dry cough that has no clear cause. It may offer a non-drug way to reduce coughing.
Hear when a new Post-Infectious Cough trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.